MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech's Big Market Movers (OvaScience)

OvaScience

Investors are believing the story OvaScience is telling of the potential of its treatments to help women with fertility challenges conceive. The company launched its Augment treatment, based on the platform technology of EggPC cells, at certain in vitro fertility clinics overseas in 2014. The company is also developing other next-generation treatments.

Last year, the Massachusetts company's share price jumped 384%, to $44.22 from $9.14 at the end of 2013. As a result, the company added $909 million to its market cap.

             
TAGS: News
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish